vs
AETHLON MEDICAL INC（AEMD）与Penumbra Inc（PEN）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc的季度营收约是AETHLON MEDICAL INC的6426.9倍（$385.4M vs $60.0K）。Penumbra Inc净利率更高（12.3% vs -2926.4%，领先2938.7%）。Penumbra Inc自由现金流更多（$68.0M vs $-2.0M）
AETHLON MEDICAL INC是一家临床阶段医疗科技企业，专注开发针对性治疗类医疗器械，核心产品血液净化器可从血液中去除有害病毒、肿瘤外泌体及其他病原体，业务聚焦传染病和肿瘤治疗赛道，主要市场覆盖北美地区。
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
AEMD vs PEN — 直观对比
营收规模更大
PEN
是对方的6426.9倍
$60.0K
净利率更高
PEN
高出2938.7%
-2926.4%
自由现金流更多
PEN
多$70.1M
$-2.0M
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $60.0K | $385.4M |
| 净利润 | $-1.8M | $47.3M |
| 毛利率 | — | 68.0% |
| 营业利润率 | -3026.4% | 15.4% |
| 净利率 | -2926.4% | 12.3% |
| 营收同比 | — | 22.1% |
| 净利润同比 | 49.4% | 40.6% |
| 每股收益（稀释后） | $-10.05 | $1.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEMDPEN
| Q4 25 | — | $385.4M | ||
| Q3 25 | — | $354.7M | ||
| Q2 25 | — | $339.5M | ||
| Q1 25 | — | $324.1M | ||
| Q4 24 | $60.0K | $315.5M | ||
| Q3 24 | $95.1K | $301.0M | ||
| Q2 24 | — | $299.4M | ||
| Q1 24 | — | $278.7M |
净利润AEMDPEN
| Q4 25 | — | $47.3M | ||
| Q3 25 | — | $45.9M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | $-1.8M | $33.7M | ||
| Q3 24 | $-2.8M | $29.5M | ||
| Q2 24 | — | $-60.2M | ||
| Q1 24 | — | $11.0M |
毛利率AEMDPEN
| Q4 25 | — | 68.0% | ||
| Q3 25 | — | 67.8% | ||
| Q2 25 | — | 66.0% | ||
| Q1 25 | — | 66.6% | ||
| Q4 24 | — | 66.8% | ||
| Q3 24 | — | 66.5% | ||
| Q2 24 | — | 54.4% | ||
| Q1 24 | — | 65.0% |
营业利润率AEMDPEN
| Q4 25 | — | 15.4% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | 12.0% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | -3026.4% | 13.6% | ||
| Q3 24 | -3050.2% | 11.7% | ||
| Q2 24 | — | -27.0% | ||
| Q1 24 | — | 4.3% |
净利率AEMDPEN
| Q4 25 | — | 12.3% | ||
| Q3 25 | — | 12.9% | ||
| Q2 25 | — | 13.3% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | -2926.4% | 10.7% | ||
| Q3 24 | -2950.2% | 9.8% | ||
| Q2 24 | — | -20.1% | ||
| Q1 24 | — | 3.9% |
每股收益（稀释后）AEMDPEN
| Q4 25 | — | $1.20 | ||
| Q3 25 | — | $1.17 | ||
| Q2 25 | — | $1.15 | ||
| Q1 25 | — | $1.00 | ||
| Q4 24 | $-10.05 | $0.88 | ||
| Q3 24 | $-16.11 | $0.75 | ||
| Q2 24 | — | $-1.55 | ||
| Q1 24 | — | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.8M | $186.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.3M | $1.4B |
| 总资产 | $6.5M | $1.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AEMDPEN
| Q4 25 | — | $186.9M | ||
| Q3 25 | — | $321.0M | ||
| Q2 25 | — | $421.8M | ||
| Q1 25 | — | $376.1M | ||
| Q4 24 | $4.8M | $324.4M | ||
| Q3 24 | $6.9M | $280.5M | ||
| Q2 24 | — | $288.3M | ||
| Q1 24 | — | $223.1M |
股东权益AEMDPEN
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | $4.3M | $1.2B | ||
| Q3 24 | $6.0M | $1.1B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
总资产AEMDPEN
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | $6.5M | $1.5B | ||
| Q3 24 | $8.8M | $1.5B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.0M | $86.5M |
| 自由现金流经营现金流 - 资本支出 | $-2.0M | $68.0M |
| 自由现金流率自由现金流/营收 | -3357.0% | 17.7% |
| 资本支出强度资本支出/营收 | 3.7% | 4.8% |
| 现金转化率经营现金流/净利润 | — | 1.83× |
| 过去12个月自由现金流最近4个季度 | — | $174.9M |
8季度趋势，按日历期对齐
经营现金流AEMDPEN
| Q4 25 | — | $86.5M | ||
| Q3 25 | — | $58.3M | ||
| Q2 25 | — | $44.9M | ||
| Q1 25 | — | $49.0M | ||
| Q4 24 | $-2.0M | $51.1M | ||
| Q3 24 | $-2.2M | $56.5M | ||
| Q2 24 | — | $22.6M | ||
| Q1 24 | — | $38.3M |
自由现金流AEMDPEN
| Q4 25 | — | $68.0M | ||
| Q3 25 | — | $42.0M | ||
| Q2 25 | — | $29.4M | ||
| Q1 25 | — | $35.5M | ||
| Q4 24 | $-2.0M | $45.7M | ||
| Q3 24 | — | $51.0M | ||
| Q2 24 | — | $18.1M | ||
| Q1 24 | — | $32.5M |
自由现金流率AEMDPEN
| Q4 25 | — | 17.7% | ||
| Q3 25 | — | 11.8% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 11.0% | ||
| Q4 24 | -3357.0% | 14.5% | ||
| Q3 24 | — | 16.9% | ||
| Q2 24 | — | 6.0% | ||
| Q1 24 | — | 11.7% |
资本支出强度AEMDPEN
| Q4 25 | — | 4.8% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | 3.7% | 1.7% | ||
| Q3 24 | 0.0% | 1.8% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 2.1% |
现金转化率AEMDPEN
| Q4 25 | — | 1.83× | ||
| Q3 25 | — | 1.27× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | 1.52× | ||
| Q3 24 | — | 1.91× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
